111 related articles for article (PubMed ID: 16463462)
1. [Tasks and expectations for drug design based on pharmacogenomics].
Uyama Y
Nihon Yakurigaku Zasshi; 2005 Dec; 126(6):432-5. PubMed ID: 16463462
[No Abstract] [Full Text] [Related]
2. The current status and future potential of personalized diagnostics: Streamlining a customized process.
Richmond TD
Biotechnol Annu Rev; 2008; 14():411-22. PubMed ID: 18606372
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic method patents and harms to follow-on innovation.
Harv Law Rev; 2013 Mar; 126(5):1370-91. PubMed ID: 25330558
[No Abstract] [Full Text] [Related]
4. [Tales of the genome. Perseverare diabolicum?].
Jordan B
Med Sci (Paris); 2012; 28(6-7):659-62. PubMed ID: 22805144
[No Abstract] [Full Text] [Related]
5. Should genetic testing go digital?
VanInsberghe M; Heyries KA; Hansen CL
Expert Rev Mol Diagn; 2012 Mar; 12(2):111-4. PubMed ID: 22369369
[No Abstract] [Full Text] [Related]
6. Improving the power of diagnostics in the era of targeted therapy and personalized healthcare.
Walk EE
Curr Opin Drug Discov Devel; 2010 Mar; 13(2):226-34. PubMed ID: 20205056
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenomics and diagnostics.
Persidis A
Nat Biotechnol; 1998 Aug; 16(8):791-2. PubMed ID: 9702782
[No Abstract] [Full Text] [Related]
8. [The development and clinical implication of genetic tests].
Nobori T
Rinsho Byori; 2002 Nov; Suppl 123():1-5. PubMed ID: 12652783
[TBL] [Abstract][Full Text] [Related]
9. Molecular medicine hones therapeutic arts to science.
Waldman SA; Terzic MR; Terzic A
Clin Pharmacol Ther; 2007 Oct; 82(4):343-7. PubMed ID: 17851568
[No Abstract] [Full Text] [Related]
10. Implementation of genetics to personalize medicine.
Chung WK
Gend Med; 2007 Sep; 4(3):248-65. PubMed ID: 18022591
[TBL] [Abstract][Full Text] [Related]
11. [Precision Oncology: Approaching the Target].
Hiddemann W
Dtsch Med Wochenschr; 2017 Nov; 142(22):1637. PubMed ID: 29078208
[No Abstract] [Full Text] [Related]
12. MRSA molecular testing.
Health Devices; 2008 Oct; 37(10):305-12. PubMed ID: 19065948
[No Abstract] [Full Text] [Related]
13. Assessing patient readiness for the clinical adoption of personalized medicine.
Issa AM; Tufail W; Hutchinson J; Tenorio J; Baliga MP
Public Health Genomics; 2009; 12(3):163-9. PubMed ID: 19204419
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacogenomics: hype or hope?].
Schwab M; Schaeffeler E; Zanger UM; Brauch H; Kroemer HK
Dtsch Med Wochenschr; 2011 Mar; 136(10):461-7. PubMed ID: 21365522
[TBL] [Abstract][Full Text] [Related]
15. Molecular diagnostics and proteomics on the outskirts of personalized medicine.
Goldknopf IL
Expert Rev Mol Diagn; 2007 Jul; 7(4):339-43. PubMed ID: 17620042
[No Abstract] [Full Text] [Related]
16. Pharmacogenomics: bench to bedside.
Weinshilboum R; Wang L
Nat Rev Drug Discov; 2004 Sep; 3(9):739-48. PubMed ID: 15340384
[TBL] [Abstract][Full Text] [Related]
17. Personalized medicine: elusive dream or imminent reality?
Lesko LJ
Clin Pharmacol Ther; 2007 Jun; 81(6):807-16. PubMed ID: 17505496
[TBL] [Abstract][Full Text] [Related]
18. Three years of promise, proposals, and progress on optimizing the benefit/risk of medicines: a commentary on the 3rd FDA-DIA-PWG-PhRMA-BIO pharmacogenomics workshop.
Salerno RA; Lesko LJ
Pharmacogenomics J; 2006; 6(2):78-81. PubMed ID: 16402087
[No Abstract] [Full Text] [Related]
19. Personalized medicine.
Jain KK
Curr Opin Mol Ther; 2002 Dec; 4(6):548-58. PubMed ID: 12596356
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenomics in psychiatry: clinical issues to be considered.
Licinio J; Wong ML
Mol Psychiatry; 2005 Jul; 10(7):615. PubMed ID: 15976808
[No Abstract] [Full Text] [Related]
[Next] [New Search]
